Web Analytics

3 Latest Announced Rounds

  • $22,000,000
    Series B

    7 Investors

    Financial Services
    Mar 4th, 2026
  • Undisclosed Amount
    Seed

    3 Investors

    Technology, Information and Media
    Mar 4th, 2026
  • $10,000,000
    Unknown

    2 Investors

    Transportation, Logistics, Supply Chain and Storage
    Mar 4th, 2026
$1,050.94M Raised in 54 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Georgiamune Inc.

start up
United States - Gaithersburg, Maryland
  • 10/08/2023
  • Series A
  • $75,000,000

Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases. Unique approaches to re-establishing immune balance and groundbreaking scientific discoveries have led to the development of pioneering immune therapeutics for cancer and autoimmune diseases.


Related People